Search
for
Sort by
Research 301–330 of 1000+
- Unsuccessful Treatment of Alopecia Areata with Simvastatin/Ezetimibe: Experience in 12 Patients
- Finasteride-Induced Myalgia and HyperCKemia
- A serious side effect of a potentially widely used cosmetic product
- Clinical Manifestations of Dermatomyositis
- Baricitinib: A Review in Severe Alopecia Areata
- Assessment of the effects of a hair lotion in women with acute telogen effluvium: a randomized controlled study
- Low Anabolic Profile in Assessing a Patients Overall Hair Loss
- Comprehensive Case Analysis: Diagnosing and Managing Myositis in Newly Diagnosed Systemic Lupus Erythematosus Patients in Indonesia.
- Visual Improvement in a Child With Periorbital Plexiform Neurofibroma Treated With Selumetinib: Case Report and Literature Review
- Association of Anti-Signal Recognition Particle Myopathy with Systemic Lupus Erythematosus
- 53274 Real-world experience of efficacy and safety of baricitinib in Korean patients with severe alopecia areata
- Pharmacotherapy of plexiform neurofibromas in patients with neurofibromatosis type 1. Possible adverse events and their management
- Lifestyle changes and Nutrition in Polycystic Ovarian Disorder: A Holistic Review
- BH15 Efficacy and safety of baricitinib in the management of severe alopecia areata over a 6-month period: a real-world experience
- Untargeted metabolomics analysis of plasma metabolic characteristics in patients with acne and insulin resistance
- 34941 Case report: Hair care routine to treat the telogen effluvium associated with post–COVID-19 infection
- Mental, Behavioral And Physical Effects Of Power Enhancing Drugs In Chronic Users
- Renal Function During Long-Term Treatment of Hypertension with Minoxidil
- Patterns of Care for Newly Diagnosed Benign Prostatic Hyperplasia in the United States
- Safety of Janus Kinase inhibitors in Patients with Alopecia Areata: A Systematic Review
- PROFILE OF SKIN CHANGES AND ITS ASSOCIATION WITH BIOCHEMICAL PARAMETERS IN HAEMODIALYSIS PATIENTS
- Adverse effects of baricitinib in comparison to methotrexate in the treatment of severe alopecia areata
- Table 1_Evaluation of the efficacy and treatment-emergent adverse events of deuruxolitinib for moderate to severe alopecia areata: a dose-ranging meta-analysis of 1,372 randomized patients.docx
- Supplementary file 1_Evaluation of the efficacy and treatment-emergent adverse events of deuruxolitinib for moderate to severe alopecia areata: a dose-ranging meta-analysis of 1,372 randomized patients.docx
- A supplementary report on the toxic manifestations of CHOP regimen in subjects with intermediate grade NHL
- Simvastatin-induced myoglobinuric acute kidney injury following ciclosporin treatment for alopecia universalis
- Safety Assessment of Ritlecitinib Based on the FDA Adverse Event Reporting System (FAERS) Database: A Real‐World Pharmacovigilance Study
- 307 Phenotypic-genotypic expansion of plectinopathy in a patient with muscular dystrophy and immune-mediated myasthenia gravis
- Hair Loss, Insulin Resistance, and Heredity in Middle-aged Women. a Population-based Study
- Treatment of canine Alopecia X with trilostane